Pain Reliever 2
NDC 71105-174
Product Information
Pain Reliever 2 is a OTC MONOGRAPH NOT FINAL-approved product labeled by Redicare Llc. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a white product. This product entry covers the primary NDC 71105-174 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
FR9
Code Structure Chart
Product Details
What is NDC 71105-174?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CAFFEINE (UNII: 3G6A5W338E)
- CAFFEINE (UNII: 3G6A5W338E) (Active Moiety)
- ACETAMINOPHEN (UNII: 362O9ITL9D)
- ACETAMINOPHEN (UNII: 362O9ITL9D) (Active Moiety)
- ASPIRIN (UNII: R16CO5Y76E)
- ASPIRIN (UNII: R16CO5Y76E) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- STEARIC ACID (UNII: 4ELV7Z65AP)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)
- MALTODEXTRIN (UNII: 7CVR7L4A2D)
- POVIDONE K30 (UNII: U725QWY32X)
- STARCH, CORN (UNII: O8232NY3SJ)
- HYPROMELLOSE 2910 (3 MPA.S) (UNII: 0VUT3PMY82)
- HYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)
- HYPROMELLOSE 2910 (50 MPA.S) (UNII: 1IVH67816N)
- SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 308297 - acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet
- RxCUI: 308297 - APAP 250 MG / ASA 250 MG / caffeine 65 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.